Welcome to our dedicated page for Runway Growth Finance news (Ticker: RWAY), a resource for investors and traders seeking the latest updates and insights on Runway Growth Finance stock.
Runway Growth Finance Corp. (RWAY) operates as a specialty finance company providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Its lending and investment activity is tied to sectors such as technology, life sciences, healthcare information and services, business services, and select consumer industries.
Recurring company updates cover operating and financial results, portfolio investments and liquidity events, net asset value and investment income, quarterly cash distributions, dividend reinvestment practices, capital-structure matters, and governance developments. News also reflects the completed acquisition of SWK Holdings Corporation, which expanded Runway Growth's healthcare and life sciences exposure.
Runway Growth Finance (Nasdaq: RWAY) declared a second quarter 2026 cash distribution of $0.33 per share.
Key dates: Declaration Date: May 5, 2026; Record Date: May 18, 2026; Payment Date: June 2, 2026. The company generally intends to distribute substantially all available earnings quarterly, subject to Board discretion and regulatory requirements.
Runway Growth Finance (Nasdaq: RWAY) will release Q1 2026 financial results after market close on May 7, 2026. The company will hold a conference call the same day at 2:00 p.m. PT / 5:00 p.m. ET to discuss results.
Participants should register on the Runway Growth investor website at least one day prior or at minimum 15 minutes before the call. A webcast replay will be available two hours after the call and archived for 90 days.
Runway Growth Finance (Nasdaq: RWAY) closed its acquisition of SWK Holdings on April 6, 2026, for a $249.0 million purchase price ($75.5M in Runway Growth shares at closing NAV $11.93 and $173.5M cash). The deal expands pro forma total assets to $1.2 billion and raises healthcare and life sciences exposure to ~32% from 14%.
The company funded $17.6 million of new investments in Q1 2026, recorded $19.0 million of portfolio liquidity events, and announced CEO David Spreng will also serve as Chief Investment Officer.
Runway Growth Finance (Nasdaq: RWAY) reported fourth-quarter and full-year 2025 results. Key metrics: total investment portfolio $927.4M, FY total investment income $137.3M, FY net investment income $56.9M ($1.55/share), and NAV $485.0M ($13.42/share). Q4 dollar-weighted yield on debt investments was 14.2%. The board declared a $0.33 quarterly dividend payable March 24, 2026. Liquidity totaled $395.2M and core leverage was ~90%. Company issued $103.25M of 7.25% notes due 2031 and repaid the April 2026 notes on January 21, 2026.
Runway Growth Finance (Nasdaq: RWAY) declared a $0.33 per share cash distribution for first quarter 2026. Key dates: Declaration Feb 25, 2026; Record Mar 10, 2026; Payment Mar 24, 2026.
The company said it generally intends to distribute substantially all available earnings quarterly, subject to Board discretion, RIC status, regulatory compliance and financial condition. The company maintains an opt‑out dividend reinvestment plan; shareholders who do not opt out will have cash dividends automatically reinvested in additional common shares.
Runway Growth Finance (Nasdaq: RWAY) will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026.
The company will discuss results on a conference call the same day at 2:00 p.m. PT / 5:00 p.m. ET. A live webcast and replay (archived for 90 days) will be available via Runway Growth Investor Relations. Participants are asked to register in advance or at least 15 minutes before the call.
Runway Growth Finance Corp (Nasdaq: RWAY) said it will partially redeem its 7.50% Notes due 2027 and fully redeem its 8.00% Notes due 2027 on March 5, 2026. The company expects to redeem $40,250,000 of 7.50% Notes and $51,750,000 of 8.00% Notes.
The redemption price per note will be $25 plus accrued and unpaid interest from March 1, 2026 up to, but not including, the redemption date.
Runway Growth Finance (Nasdaq: RWAY) priced an underwritten public offering of $100.0 million aggregate principal amount of 7.25% notes due February 3, 2031, with expected net proceeds of approximately $97.0 million. The Notes pay interest quarterly, first payment on March 1, 2026, and may be redeemed on or after February 3, 2028. The company granted a 30-day option to purchase up to an additional $15.0 million of Notes for overallotments. Runway intends to use proceeds to repay outstanding indebtedness, including redeeming its 8.00% notes due 2027 ($51.75M) and its 7.50% notes due 2027 ($80.5M), and for general corporate purposes.
Runway Growth Finance (Nasdaq: RWAY) commenced an underwritten offering of unsecured notes on January 26, 2026, with plans to apply to list the Notes on the Nasdaq Global Select Market and, if approved, to begin trading within 30 days of original issue date. The interest rate and final terms will be set at pricing. Net proceeds are intended to repay outstanding indebtedness (including up to $51.75 million of 8.00% notes due December 28, 2027), finance the previously announced acquisition of SWK Holdings, and for general corporate purposes.
Joint book-running managers and co-managers have been engaged, and a preliminary prospectus supplement (dated January 26, 2026) and accompanying prospectus are filed with the SEC.
Runway Growth Finance (Nasdaq: RWAY) reported a fourth-quarter 2025 portfolio and transaction update. During Q4 the company funded $42.9 million across seven investments, including a $20.0M mobility deal, a $10.0M SPV commitment, and a $20.0M Shield Therapeutics facility (with $2.0M funded at close); follow-ons totaled $10.9M. Q4 liquidity events totaled $77.8M, driven by principal repayments from Synack ($45.0M) and Dejero Labs ($14.7M), an assignment of $15.0M in Kin Insurance, plus other repayments.
The pending acquisition of SWK Holdings is expected to close late Q1 2026 pending regulatory approvals; Runway filed a Form N-14 on Nov 18, 2025. As of Dec 31, 2025 the portfolio included 40 debt investments to 31 companies and 72 equity investments in 48 companies, with 24 companies holding both debt and equity positions.